MONITORING THE GRANULATION PROCESS IN A HIGH SHEAR MIXER GRANULATOR - AN EVALUATION OF 3 APPROACHES TO INSTRUMENTATION

被引:19
作者
KOPCHA, M [1 ]
ROLAND, E [1 ]
BUBB, G [1 ]
VADINO, WA [1 ]
机构
[1] SPECIALTY MEASUREMENTS INT,PITTSTOWN,NJ 08867
关键词
D O I
10.3109/03639049209052411
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A high shear vertical mixer/granulator was instrumented to monitor power consumption, direct torque and reactive torque. All three methods were used to determine their ability in describing the granulation operation. Of the three methods used, direct torque generated the most descriptive profile of the granulation process. Two formulations were manufactured making use of direct torque in detailing the massing process. End-points were determined and the granulations produced were shown to yield tablets with acceptable hardnesses. One formulation was intentionally overwetted and the change in direct torque monitored to demonstrate the ability of the transducer to detail the massing process. Large fluctuations in torque, during the terminal phase of granulating, were seen and related to the doughy consistency of the final product. It was concluded that torque measurements, preferably direct, are needed to more precisely define granulation end-points. These types of measurements are needed to optimize the granulation unit operation during product development.
引用
收藏
页码:1945 / 1968
页数:24
相关论文
共 13 条
[1]  
Bier H., 1979, PHARM IND, V41, P375
[2]   USE OF MIXER-TORQUE MEASUREMENTS AS AN AID TO OPTIMIZING WET GRANULATION PROCESS [J].
GHANTA, SR ;
SRINIVAS, R ;
RHODES, CT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1984, 10 (02) :305-311
[3]   GRANULATION IN HIGH-SPEED MIXERS .6. EFFECTS OF PROCESS CONDITIONS ON POWER-CONSUMPTION AND GRANULE GROWTH [J].
HOLM, P ;
SCHAEFER, T ;
KRISTENSEN, HG .
POWDER TECHNOLOGY, 1985, 43 (03) :225-233
[4]  
HUNTER BM, 1973, J PHARM PHARMACOL, V25, pP71
[5]  
KAY D, 1978, MANUF CHEMIST AER N, V49, P45
[6]   GRANULATION - A REVIEW OF PHARMACEUTICAL WET-GRANULATION [J].
KRISTENSEN, HG ;
SCHAEFER, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (4-5) :803-872
[7]  
LEUENBERGER H, 1982, PHARM ACTA HELV, V57, P72
[8]  
Leuenberger H., 1983, ACTA PHARM TECHNOL, V29, P274
[9]  
LEUENBERGER H, 1979, PHARM TECHNOL, V2, P35
[10]  
LEUENBERGER H, 1984, CHEM IND, V16, P281